Slovākija - slovāku - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

virbac, francúzsko - sol.

Slovākija - slovāku - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

pharmagal, slovenská republika - inj.

Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

octapharma (ip) sprl, belgicko - koagulačné faktory ix, ii, vii a x v kombinácii - 75 - substitutio sanguinis (a krvnÉ derivÁty)

Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

theramex ireland limited, Írsko - levonorgestrel a etinylestradiol - 17 - anticoncipientia

Eiropas Savienība - slovāku - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - imunosupresíva - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikovaný na liečbu dospelých predtým neliečených pacientov s myelómom je mladších, ktorí nie sú spôsobilí na transplantáciu. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).